S van Riel, E Thunnissen, D Heideman, E F Smit, B Biesma. Show Affiliations »
Abstract
Entities: Disease Gene Species
Mesh: See more » Adenocarcinoma/complicationsAdenocarcinoma/drug therapyAdenocarcinoma/geneticsAdultAntineoplastic Agents/therapeutic useCisplatin/therapeutic useDeoxycytidine/analogs & derivativesDeoxycytidine/therapeutic useDocetaxelErbB Receptors/geneticsErlotinib HydrochlorideFemaleHumansLung Neoplasms/complicationsLung Neoplasms/drug therapyLung Neoplasms/geneticsMutationNeoplasm Recurrence, LocalQuinazolines/therapeutic useSmall Cell Lung Carcinoma/complicationsSmall Cell Lung Carcinoma/drug therapySmall Cell Lung Carcinoma/geneticsTaxoids/therapeutic use
Substances: See more » Antineoplastic AgentsQuinazolinesTaxoidsDeoxycytidineDocetaxelgemcitabineErlotinib HydrochlorideEGFR protein, humanErbB ReceptorsCisplatin
Year: 2012 PMID: 23079729 DOI: 10.1093/annonc/mds525
Source DB: PubMed Journal: Ann Oncol ISSN: 0923-7534 Impact factor: 32.976